NuCana (NCNA) EBITDA (2017 - 2025)

NuCana (NCNA) has 9 years of EBITDA data on file, last reported at -$3.7 million in Q4 2025.

• For the quarter ending Q4 2025, EBITDA fell 235.47% year-over-year to -$3.7 million; the trailing twelve-month figure through Dec 2025 stood at -$24.1 million (up 16.9% YoY), and the FY2025 full-year result was -$26.5 million, up 9.06% from the prior year.
• EBITDA retreated to -$3.7 million in Q4 2025, from -$1.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$1.1 million in Q3 2025 to a low of -$21.2 million in Q4 2021.
• A 5-year average of -$10.4 million and a median of -$10.5 million in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA jumped 90.18% in 2024 and slumped 235.47% in 2025, its largest moves.
• Tracing NCNA's EBITDA over 5 years: stood at -$21.2 million in 2021, then grew by 4.63% to -$20.2 million in 2022, then soared by 44.13% to -$11.3 million in 2023, then jumped by 90.18% to -$1.1 million in 2024, then tumbled by 235.47% to -$3.7 million in 2025.
• Business Quant data shows NCNA's EBITDA at -$3.7 million in Q4 2025, -$1.1 million in Q3 2025, and -$15.8 million in Q2 2025.